This post is almost a double-header if you will. Partially about Novo Nordisk and part about mySugr.
The first part is about the connected pens that Novo Nordisk is planning on releasing in 2019. These connected insulin pens will be “connected” to data systems, which currently seem to be Dexcom, Glooko and Roche (mySugr).
I am excited about this because I switched over to insulin pens earlier this year and I NEVER track my insulin intake now. I think I have maybe 10 times in the past 6 months of using Dexcom and mySugr. These connected pens will help me with tracking my insulin dosing.
Here’s a quote from Novo Nordisk on the partnerships from a recent press release:
“Our non-exclusive partnership strategy allows us to integrate with the various digital platforms that people are already using to help manage their diabetes,” said Camilla Sylvest, executive vice president of Commercial Strategy & Corporate Affairs at Novo Nordisk. “We firmly believe that this will help more people realise the full benefit of our innovative medicines and begin to ease the mental burden of diabetes treatment for those individuals.”
When the news broke that mySugr will be part of this integration, I was ecstatic. I test my sugar and then I correct based off of that. My blood sugar levels are automatically sent to the mySugr app, but I have to manually input how much insulin I am taking, which I am just not good at. Same goes with the Dexcom Clarity app, I don’t typically open up the app and input my insulin dosage. Hmm…I’m starting to hear a new 2019 goal!
If you would like to read more about this, check out the press release here.
Like what you read? Then sign up for The Life of a Diabetic newsletter to get all the week’s posts delivered directly to your email every Saturday morning.
Exciting news, indeed! Thanks for sharing, Chris!
Yes those pens are super cool. I think this is exciting for people who use pens.